Astellas Pharma Inc (ALPMY)

17.90 +0.07  +0.39% OTC Markets Jun 24, 15:46 USD

Astellas Pharma Revenue (Quarterly):

2.914B for March 31, 2021
View 4,000+ financial data types
Browse...
View Full Chart

Revenue (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Revenue (Quarterly) Data

View and export this data going back to 2008. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2021 2.914B
Dec. 31, 2020 3.116B
Sept. 30, 2020 2.907B
June 30, 2020 2.853B
March 31, 2020 2.868B
Dec. 31, 2019 3.109B
Sept. 30, 2019 2.949B
June 30, 2019 3.040B
March 31, 2019 2.736B
Dec. 31, 2018 3.175B
Sept. 30, 2018 2.853B
June 30, 2018 3.017B
March 31, 2018 2.776B
Dec. 31, 2017 3.185B
Sept. 30, 2017 2.860B
June 30, 2017 2.903B
March 31, 2017 2.692B
Dec. 31, 2016 3.243B
Sept. 30, 2016 3.067B
June 30, 2016 3.127B
March 31, 2016 2.665B
Dec. 31, 2015 3.113B
Sept. 30, 2015 2.814B
June 30, 2015 2.833B
March 31, 2015 2.472B
   
Dec. 31, 2014 3.133B
Sept. 30, 2014 2.880B
June 30, 2014 2.889B
March 31, 2014 2.641B
Dec. 31, 2013 3.228B
Sept. 30, 2013 2.777B
June 30, 2013 2.729B
March 31, 2013 2.462B
Dec. 31, 2012 3.428B
Sept. 30, 2012 2.971B
June 30, 2012 3.034B
March 31, 2012 2.594B
Dec. 31, 2011 3.618B
Sept. 30, 2011 2.989B
June 30, 2011 3.085B
March 31, 2011 2.670B
Dec. 31, 2010 3.300B
Sept. 30, 2010 2.609B
June 30, 2010 2.581B
March 31, 2010 2.227B
Dec. 31, 2009 3.096B
Sept. 30, 2009 2.594B
June 30, 2009 2.588B
March 31, 2009 2.210B
Dec. 31, 2008 2.778B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Benchmarks

Takeda Pharmaceutical Co Ltd 7.273B
Sosei Group Corp 11.40M
PeptiDream Inc 13.78M

Revenue (Quarterly) Range, Past 5 Years

Minimum 2.692B Mar 2017
Maximum 3.243B Dec 2016
Average 2.969B

News

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.